Cyclospora and Isospora Examination
Test Code: 10018
CPT Code(s): 87015, 87207
Test Code: 10018
CPT Code(s): 87015, 87207
Test Code: 13954
CPT Code: 87040
Clinical Significance: Culture, Blood with Reflex to Molecular Identification - Bacterial sepsis constitutes one of the most serious infectious diseases. The detection of microorganisms in a patient's blood has importance in the diagnosis and prognosis of endocarditis, septicemia, or chronic bacteremia.
Test Code: 916
CPT Code(s): 80164
Methodology: Immunoassay (IA)
Test code: 763
CPT code(s): 85790
Methodology: Photo-Optical Clot Detection
Clinical Significance: The aPTT is a screening test that will detect deficiencies or inhibitors to the intrinsic (Factors VIII, IX, XI and XII) and common (Factors II, V, X and fibrinogen) pathway coagulation factors.
Test Code: 593
CPT Code(s): 83615
Methodology: Spectrophotometry (SP)
Clinical Significance: Elevations in serum lactate dehydrogenase occur from myocardial infarction, liver disease, pernicious and megaloblastic anemia, pulmonary emboli, malignancies, and muscular dystrophy. Since lactic dehydrogenase is present in many body tissues, it's diagnosis usefulness is limited. Tissue specificity may be enhanced by isoenzyme analysis.
Test Code: 654
CPT Code(s): 86308
Methodology: Agglutination
Clinical Significance: Heterophile antibodies, in patients with infectious mononucleosis, may be present as early as the fourth day of illness, and by the twenty-first day of illness, 90% of patients will exhibit a positive test. The Epstein-Barr virus causes infectious mononucleosis.
Alternative Name(s): Infectious Mononucleosis, Mono Screen
Breast Plus Panel without BRCA (TP53, STK11, PTEN, CDH1, PALB2)
Test Code: 92586
CPT Code(s): 81321, 81323, 81404, 81405 (x2), 81406 (x2), 81479
Clinical Significance: CDH1, PALB2, PTEN, STK11 and TP53 are tumor suppressor genes, where inherited mutations significantly increase breast cancer risk. Sequence analysis and deletion/duplication analysis of these five genes can explain an additional 3% to 4.5% of hereditary breast cancers.
Test Code: 92573
CPT Code(s): 81162
Includes: If the Interpretation Summary is not one of the following three results: Positive for a known Pathogenic Mutation; Positive for a likely Pathogenic Mutation; Positive for a likely Pathogenic Mutation and a variant with unknown significance, then TP53, PTEN, CDH1, STK11, and PALB2 will be performed at an additional charge (CPT code(s) 81321, 81323, 81404, 81405 (x2), 81406 (x2), 81479).